Jennifer S Gewandter Selected Research

Jennifer S Gewandter Research Topics

Disease

25	Pain (Aches) 01/2022 - 12/2013
14	Peripheral Nervous System Diseases (PNS Diseases) 01/2022 - 07/2014
7	Neoplasms (Cancer) 01/2022 - 12/2013
7	Chronic Pain 11/2021 - 06/2015
4	Neuralgia (Stump Neuralgia) 01/2022 - 11/2018
4	Postherpetic Neuralgia 01/2021 - 07/2015
4	Breast Neoplasms (Breast Cancer) 07/2020 - 04/2015
3	Low Back Pain (Lumbago) 01/2021 - 07/2015
2	Virus Diseases (Viral Diseases) 01/2021 - 07/2015
2	Postoperative Pain 01/2021 - 07/2015
2	Dermatitis 07/2020 - 05/2018
2	Cancer Pain 01/2019 - 05/2017
2	Spinal Stenosis (Stenosis, Spinal) 05/2015 - 01/2015
2	Hyperoxia 08/2011 - 12/2009
1	Hyperalgesia 01/2022
1	Respiratory Insufficiency (Respiratory Failure) 11/2021
1	Opioid-Related Disorders (Opiate Addiction) 11/2021
1	Polyneuropathies (Polyneuropathy) 01/2020
1	Failed Back Surgery Syndrome 01/2019
1	Sciatica (Sciatic Neuralgia) 11/2018
1	Hypesthesia (Numbness) 04/2018
1	Sarcopenia 11/2015
1	Substance-Related Disorders (Drug Abuse) 06/2015
1	Myalgia 04/2015
1	Temporomandibular Joint Disorders (Temporomandibular Joint Disorder) 04/2015
1	Mitochondrial Diseases (Mitochondrial Disease) 10/2014
1	Ataxia Telangiectasia (Louis Bar Syndrome) 10/2014
1	Adenocarcinoma of Lung 10/2014
1	Second Primary Neoplasms (Neoplasms, Second) 09/2011
1	Lung Diseases (Lung Disease) 12/2009
1	Smith-Lemli-Opitz Syndrome 06/2005

Drug/Important Bio-Agent (IBA)

13	Analgesics (Analgesic Drugs)IBA 01/2022 - 12/2014
5	Pregabalin (Lyrica)FDA Link 01/2022 - 01/2015
5	Anesthetics (Anesthetic Agents)IBA 01/2019 - 04/2015
3	Pharmaceutical PreparationsIBA 01/2020 - 06/2015
2	ElementsIBA 01/2021 - 07/2015
2	CurcuminIBA 07/2020 - 05/2018
2	Duloxetine Hydrochloride (Cymbalta)FDA Link 01/2020 - 11/2018
2	Gabapentin (Neurontin)FDA LinkGeneric 01/2019 - 11/2018
2	Proteins (Proteins, Gene)FDA Link 08/2011 - 12/2009
1	Antineoplastic Agents (Antineoplastics)IBA 01/2022
1	PlacebosIBA 01/2022
1	Opioid Analgesics (Opioids)IBA 11/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Indicators and Reagents (Reagents)IBA 01/2020
1	Fentanyl (Sublimaze)FDA LinkGeneric 01/2019
1	NAD (NADH)IBA 11/2018
1	PlatinumIBA 04/2018
1	AlkaloidsIBA 04/2018
1	taxaneIBA 04/2018
1	IceIBA 11/2016
1	Buprenorphine (Subutex)FDA LinkGeneric 06/2015
1	Dextropropoxyphene (Darvon)FDA LinkGeneric 05/2015
1	hydroxide ionIBA 05/2015
1	Acetaminophen (Paracetamol)FDA LinkGeneric 05/2015
1	Oxymorphone (Numorphan)FDA LinkGeneric 05/2015
1	Hormones (Hormone)IBA 04/2015
1	Tamoxifen FDA LinkGeneric 04/2015
1	Aromatase InhibitorsIBA 04/2015
1	Diphenhydramine (Benadryl)FDA LinkGeneric 01/2015
1	Ataxia Telangiectasia Mutated ProteinsIBA 10/2014
1	CTGCAG-specific type II deoxyribonucleasesIBA 10/2014
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2014
1	Hemagglutinins (Hemagglutinin)IBA 10/2014
1	Mitochondrial DNA (mtDNA)IBA 10/2014
1	DNA (Deoxyribonucleic Acid)IBA 10/2014
1	AntigensIBA 10/2014
1	EpitopesIBA 10/2014
1	Ketamine FDA LinkGeneric 07/2014
1	Amitriptyline (Elavil)FDA LinkGeneric 07/2014
1	Messenger RNA (mRNA)IBA 08/2011
1	Small Interfering RNA (siRNA)IBA 08/2011
1	OligonucleotidesIBA 08/2011
1	NucleotidesIBA 08/2011
1	Oxygen (Dioxygen)IBA 08/2011
1	Endoplasmic Reticulum Chaperone BiPIBA 12/2009
1	Therapeutic UsesIBA 12/2009
1	TunicamycinIBA 12/2009
1	CholesterolIBA 06/2005
1	Simvastatin (Zocor)FDA LinkGeneric 06/2005

Therapy/Procedure

13	Drug Therapy (Chemotherapy) 01/2022 - 07/2014
6	Therapeutics 01/2020 - 04/2015
3	Radiotherapy 07/2020 - 12/2013
2	Secondary Prevention 01/2021 - 07/2015
2	Nerve Block (Nerve Blocks) 05/2017 - 12/2014
2	Aftercare (After-Treatment) 05/2015 - 09/2011
1	Spinal Cord Stimulation 01/2021
1	Withholding Treatment 10/2019
1	Drug Tapering 10/2019
1	Transcutaneous Electric Nerve Stimulation (TENS) 05/2019
1	Analgesia 01/2019
1	Investigational Therapies (Experimental Therapy) 01/2018
1	Precision Medicine 09/2016
1	Massage (Zone Therapy) 04/2016
1	Physical Therapy Modalities (Physical Therapy Technique) 04/2016
1	Activities of Daily Living (ADL) 11/2015